Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry

Mohammad Movahedi; Angela Cesta; Xiyuing Li; Edward C. Keystone; Claire Bombardier; the OBRI Investigators

doi:10.3899/jrheum.211066

Research ArticleRheumatoid Arthritis

Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry

Mohammad Movahedi, Angela Cesta, Xiyuing Li, Edward C. Keystone, Claire Bombardier and the OBRI Investigators

The Journal of Rheumatology May 2022, 49 (5) 447-453; DOI: https://doi.org/10.3899/jrheum.211066

Mohammad Movahedi

1M. Movahedi, MD, PhD, OBRI, Toronto General Research Institute, University Health Network, Toronto, and Institute of Health Policy, Management, and Evaluation (IHPME), University of Toronto, Toronto;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Mohammad Movahedi

Angela Cesta

2A. Cesta, MSc, X. Li, MSc, OBRI, Toronto General Research Institute, University Health Network, Toronto;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiyuing Li

2A. Cesta, MSc, X. Li, MSc, OBRI, Toronto General Research Institute, University Health Network, Toronto;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Edward C. Keystone

3E.C. Keystone, MD, MaRS Center, Toronto;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claire Bombardier

4C. Bombardier, MD, OBRI, Toronto General Research Institute, University Health Network, Toronto, Division of Rheumatology, Department of Medicine, University of Toronto, and Department of Medicine and IHPME, University of Toronto, Toronto, Ontario, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Claire Bombardier

Article
Figures & Data
References
Info & Metrics
PDF
eLetters

PreviousNext

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 49, Issue 5

1 May 2022

Table of Contents
Table of Contents (PDF)
Index by Author
Editorial Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry